Internalization of locked nucleic acids/DNA hybrid oligomers into escherichia coli

BioResearch Open Access

Volumn 1, Issue 5, 2012, Pages 260-263

  Traglia, German M ^a   Sala, Carol Davies ^a   Bass, Juan I Fuxman ^b,d   Soler Bistué, Alfonso J C ^a,c,e   Zorreguieta, Angeles ^a   Ramírez, María Soledad ^a,c   Tolmasky, Marcelo E ^c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b ACADEMIA NACIONAL DE MEDICINA   (Argentina)

^c CALIFORNIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e INSTITUT PASTEUR   (France)

Author keywords

Drug discovery; Drug resistance; Gene therapy; Microbiology; Nucleic acids

Indexed keywords

ALEXA FLUOR 488; LOCKED NUCLEIC ACID; OLIGOMER; UNCLASSIFIED DRUG;

ANTISENSE THERAPY; ARTICLE; BACTERIAL CELL; CELL CULTURE; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; CYTOPLASM; DRUG PENETRATION; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE DELIVERY SYSTEM; NONHUMAN; PRIORITY JOURNAL;

EID: 84884243598     PISSN: None     EISSN: 21647860     Source Type: Journal    
DOI: 10.1089/biores.2012.0257     Document Type: Article

References (27)

1. Marwick C. First "antisense"drug will treat CMV retinitis. JAMA. 1998;280:871.
2. Kole R, Krainer AR, Altman S. RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nature Rev Drug Discov. 2012;11:125-140.
3. Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur J Biochem. 2003;270: 1628-1644.
4. Rasmussen LC, Sperling-Petersen HU, Mortensen KK. Hitting bacteria at the heart of the central dogma: sequencespecific inhibition. Microb Cell Fact. 2007;6:24.
5. Chrisey LA, Walz SE, Pazirandeh M, et al. Internalization of oligodeoxyribonucleotides by Vibrio parahaemolyticus. Antisense Res Dev. 1993;3:367-381.
6. Harth G, Zamecnik PC, Tabatadze D, et al. Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis. Proc Natl Acad Sci USA. 2007;104:7199-7204.
7. Good L, Sandberg R, Larsson O, et al. Antisense PNA effects in Escherichia coli are limited by the outer-membrane LPS layer. Microbiology. 2000;146:2665-2670.
8. Mellbye BL, Puckett SE, Tilley LD, et al. Variations in amino acid composition of antisense peptide-phosphorodiamidate morpholino oligomer affect potency against Escherichia coli in vitro and in vivo. Antimicrob Agents Chemother. 2009; 53:525-530.
9. Nikravesh A, Dryselius R, Faridani OR, et al. Antisense PNA accumulates in Escherichia coli and mediates a long post-antibiotic effect. Mol Ther. 2007;15:1537-1542.
10. Mellbye BL, Weller DD, Hassinger JN, et al. Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo. J Antimicrob Chemother. 2010;65:98-106.
11. Deere J, Iversen P, Geller BL. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli. Antimicrob Agents Chemother. 2005;49:249-255.
12. Lundblad EW, Altman S. Inhibition of gene expression by RNase P. N Biotechnol. 2010;27:212-221.
13. Shen N, Ko JH, Xiao G, et al. Inactivation of expression of several genes in a variety of bacterial species by EGS technology. Proc Natl Acad Sci USA. 2009;106:8163-8168.
14. Kumar R, Singh SK, Koshkin AA, et al. The first analogues of LNA (locked nucleic acids): phosphorothioate-LNA and 2¢thio-LNA. Bioorg Med Chem Lett. 1998;8:2219-2222.
15. Soler Bistue AJ, Martin FA, Vozza N, et al. Inhibition of aac(6')-Ib-mediated amikacin resistance by nuclease-resistant external guide sequences in bacteria. Proc Natl Acad Sci USA. 2009;106:13230-13235.
16. Wahlestedt C, Salmi P, Good L, et al. Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc Natl Acad Sci USA. 2000;97:5633-5638.
17. Crinelli R, Bianchi M, Gentilini L, et al. Design and characterization of decoy oligonucleotides containing locked nucleic acids. Nucleic Acids Res. 2002;30:2435-2443.
18. Chabot S, Orio J, Castanier R, et al. LNA-based oligonucleotide electrotransfer for miRNA inhibition. Mol Ther. 2012;20: 1590-1598.
19. Sun Z, Xiang W, Guo Y, et al. Inhibition of hepatitis B virus (HBV) by LNA-mediated nuclear interference with HBV DNA transcription. Biochem Biophys Res Commun. 2011; 409:430-435.
20. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2001.
21. Eriksson M, Nielsen PE, Good L. Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli. J Biol Chem. 2002;277:7144-7147.
22. Tilley LD, Hine OS, Kellogg JA, et al. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture. Antimicrob Agents Chemother. 2006;50:2789-2796.
23. Wesolowski D, Tae HS, Gandotra N, et al. Basic peptidemorpholino oligomer conjugate that is very effective in killing bacteria by gene-specific and nonspecific modes. Proc Natl Acad Sci USA. 2011;108:16582-16587.
24. Geller BL. Antibacterial antisense. Curr Opin Mol Ther. 2005;7:109-113.
25. Good L, Stach JE. Synthetic RNA silencing in bacteria antimicrobial discovery and resistance breaking. Front Microbiol. 2011;2:185.
26. Torres AG, Threlfall RN, Gait MJ. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2¢-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents. Artif DNA PNA XNA. 2011;2:71-78.
27. Stein CA, Hansen JB, Lai J, et al. Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res. 2010;38:e3.